Since its founding in 1993, our company has expanded its business area starting from consulting for drug licensing, import, and sales of innovative drugs. In 2009, we completed the manufacturing technology of PDRN, a tissue regenerative raw material using marine resources, for the first time in Korea. We laid the foundation as a comprehensive pharmaceutical company by obtaining certification as a pharmaceutical GMP factory in 2013, listing on the KOSDAQ in July 2015, and being certified as an Innovative Pharmaceutical Company in 2016.
Furthermore, PharmaResearch has a pipeline for “Total Aesthetic Solution” with reinforced PDRN-based pharmaceuticals, aesthetic medical devices, and derma-cosmetics, and adding lineup of botulinum toxin product through business expansion. We are preparing for a second leap forward in the anti-aging market.
In addition, we will not stop trying until the day that we are recognized as a global pharmaceutical company leading the improvement of quality of life and regenerative medicine as strengthening our network with domestic and overseas excellent research institutions and global bio-companies.